{
    "N/R/U": null,
    "Applicant": "Vericel Corporation",
    "BLA Number": "761192",
    "Proprietary Name": "Nexobrid",
    "BLA Type": "351(a)",
    "Strength": "8.8% (4.85GM)",
    "Dosage Form": "For Topical Gel",
    "Route of Administration": "Topical",
    "Product Presentation": "Single-Use Jar",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "28-Dec-22",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2010",
    "Product Number": "2",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "15-Aug-31",
    "drug": [
        {
            "name": "anacaulase-bcdb"
        }
    ]
}